| |
| |
|
| Insider
Information: |
Burgstahler David F |
| Relationship: |
Director, 10% Owner |
| City: |
New York |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
7 |
|
| Direct
Shares |
127,648 |
|
|
Indirect Shares
|
32,047,702 |
|
|
| Direct
Value |
$3,019,063 |
|
|
|
Indirect Value
|
$27,265,596 |
|
|
| Total
Shares |
32,175,350 |
|
|
| Total
Value |
$30,284,659 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
9
|
0
|
|
Stock
price went up :
|
8
|
0
|
| Stock
price went down : |
1
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
8.0
|
0.0
|
| Percentage
Gain/Loss : |
 123.1%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Warner Chilcott Ltd |
WCRX |
Director |
2008-03-07 |
20,000 |
2007-03-12 |
0 |
Premium* |
|
|
Angiodynamics Inc |
ANGO |
Director, 10% Owner |
2017-04-12 |
23,988 |
2017-04-12 |
381,406 |
Premium* |
|
|
Syneos Health Inc |
SYNH |
Director, 10% Owner |
2017-05-23 |
38,758 |
2017-05-23 |
3,648 |
Premium* |
|
|
Lantheus Holdings, Inc. |
LNTH |
Director |
2017-09-07 |
13,248 |
2017-09-07 |
39,831 |
Premium* |
|
|
Wideopenwest, Inc. |
WOW |
Director |
2018-01-10 |
31,654 |
2018-01-10 |
3,733 |
Premium* |
|
|
Organogenesis Holdings Inc |
ORGO |
|
2019-08-19 |
0 |
2021-05-14 |
7,888,220 |
Premium* |
|
|
Osmotica Pharmaceuticals Plc |
OSMT |
Director, 10% Owner |
2020-11-20 |
0 |
2023-01-27 |
23,730,864 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
65 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| LNTH |
Lantheus Holdings, Inc. |
Director |
– • – |
2017-08-14 |
4 |
D |
$17.15 |
$91,985,551 |
I/I |
(5,363,589) |
0 |
0 |
- |
|
| OSMT |
Osmotica Pharmaceuticals ... |
Director |
– • • |
2020-11-20 |
4 |
D |
$0.00 |
$0 |
I/I |
(4,936,926) |
0 |
0 |
- |
|
| OSMT |
Osmotica Pharmaceuticals ... |
Director |
– • • |
2023-01-27 |
4 |
D |
$0.00 |
$0 |
I/I |
(1,032,995) |
0 |
0 |
- |
|
| LNTH |
Lantheus Holdings, Inc. |
Director |
– • – |
2017-08-14 |
4 |
A |
$0.00 |
$0 |
I/I |
1,562 |
1,562 |
0 |
- |
|
| ANGO |
Angiodynamics Inc |
Director |
– • • |
2012-08-07 |
4 |
A |
$0.00 |
$0 |
D/D |
2,850 |
2,850 |
0 |
- |
|
| SYNH |
Syneos Health Inc |
|
• • – |
2016-08-24 |
4 |
A |
$0.00 |
$0 |
I/I |
3,648 |
3,648 |
0 |
- |
|
| WOW |
Wideopenwest, Inc. |
Director |
– • – |
2018-01-10 |
4 |
A |
$0.00 |
$0 |
I/I |
3,733 |
3,733 |
0 |
- |
|
| ANGO |
Angiodynamics Inc |
Director |
– • • |
2013-08-06 |
4 |
A |
$0.00 |
$0 |
D/D |
3,000 |
5,850 |
0 |
- |
|
| ANGO |
Angiodynamics Inc |
Director |
– • – |
2013-10-23 |
4 |
A |
$0.00 |
$0 |
D/D |
1,616 |
7,466 |
0 |
- |
|
| WCRX |
Warner Chilcott Ltd |
Director |
– • – |
2007-03-12 |
4 |
B |
$14.77 |
$147,700 |
D/D |
10,000 |
10,000 |
2.39 |
- |
|
| LNTH |
Lantheus Holdings, Inc. |
Director |
– • – |
2017-08-14 |
4 |
A |
$0.00 |
$0 |
D/D |
13,248 |
13,248 |
0 |
- |
|
| ANGO |
Angiodynamics Inc |
Director |
– • – |
2014-08-12 |
4 |
A |
$0.00 |
$0 |
D/D |
6,193 |
13,659 |
0 |
- |
|
| ANGO |
Angiodynamics Inc |
Director |
– • – |
2015-07-22 |
4 |
A |
$0.00 |
$0 |
D/D |
5,266 |
18,925 |
0 |
- |
|
| WCRX |
Warner Chilcott Ltd |
Director |
– • – |
2008-03-07 |
4 |
B |
$15.65 |
$156,500 |
D/D |
10,000 |
20,000 |
2.39 |
- |
|
| ANGO |
Angiodynamics Inc |
Director |
– • – |
2016-07-27 |
4 |
A |
$0.00 |
$0 |
D/D |
5,063 |
23,988 |
0 |
- |
|
| WOW |
Wideopenwest, Inc. |
Director |
– • – |
2018-01-10 |
4 |
A |
$0.00 |
$0 |
D/D |
31,654 |
31,654 |
0 |
- |
|
| SYNH |
Syneos Health Inc |
|
• • – |
2016-08-24 |
4 |
A |
$0.00 |
$0 |
D/D |
33,336 |
33,336 |
0 |
- |
|
| SYNH |
Syneos Health Inc |
Director |
– • • |
2016-09-15 |
4 |
A |
$0.00 |
$0 |
D/D |
1,729 |
35,065 |
0 |
- |
|
| SYNH |
Syneos Health Inc |
Director |
– • • |
2016-09-19 |
4 |
B |
$43.19 |
$43,187 |
D/D |
1,000 |
36,065 |
3.92 |
- |
|
| LNTH |
Lantheus Holdings, Inc. |
Director |
– • – |
2017-09-07 |
4 |
S |
$16.56 |
$1,704,984 |
I/I |
(102,958) |
38,269 |
0 |
- |
|
| SYNH |
Syneos Health Inc |
Director |
– • • |
2017-05-23 |
4 |
A |
$0.00 |
$0 |
D/D |
2,693 |
38,758 |
0 |
- |
|
| LNTH |
Lantheus Holdings, Inc. |
Director |
– • – |
2017-09-06 |
4 |
S |
$16.59 |
$345,454 |
I/I |
(20,823) |
52,684 |
0 |
- |
|
| LNTH |
Lantheus Holdings, Inc. |
Director |
– • – |
2017-09-05 |
4 |
S |
$17.08 |
$888,331 |
I/I |
(52,010) |
55,983 |
0 |
- |
|
| LNTH |
Lantheus Holdings, Inc. |
Director |
– • – |
2017-09-01 |
4 |
S |
$17.10 |
$102,600 |
I/I |
(6,000) |
64,425 |
0 |
- |
|
| LNTH |
Lantheus Holdings, Inc. |
Director |
– • – |
2017-08-31 |
4 |
S |
$17.36 |
$2,638,737 |
I/I |
(152,001) |
65,263 |
0 |
- |
|
65 Records found
|
|
Page 1 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
